Literature DB >> 18556075

Peripheral but not central leptin treatment increases numbers of circulating NK cells, granulocytes and specific monocyte subpopulations in non-endotoxaemic lean and obese LEW-rats.

Philipp Haas1, Rainer H Straub, Sammy Bedoui, Heike Nave.   

Abstract

Leptin, a hormone mainly generated by adipocytes, acts centrally in the hypothalamus to regulate body weight and energy expenditure. However, there is strong evidence that leptin is also involved in cell-mediated immunity and cytokine crosstalk. In the present study the effects of diet-induced obesity and central and peripheral leptin treatment on leukocyte subsets and cytokine production was investigated. Leptin was injected either intravenously (i.v.) or intracerebroventricularly (i.c.v.) in male endotoxaemic or vehicle-treated healthy LEW-rats. Numbers of blood leukocyte subsets were analysed by FACS and cytokines (TNF-alpha and IL-6) by ELISA. Results showed that peripheral rather than central leptin treatment was able to significantly increase numbers of granulocytes, NK cells and monocytes. Three-colour staining revealed that the increase of ED9(+) monocytes was most likely due to the mobilization of two distinct monocyte subsets, predominantly ED9(+)CD4(-)NKR-P1A(+) and ED9(+)CD4(+)NKR-P1A(+). ELISA analysis revealed significantly elevated TNF-alpha levels in obese animals compared to their lean littermates, while IL-6 failed to show notable changes. In conclusion, the data of the present study revealed that leptin application induces a nutrition- and application-site dependent increase of circulating NK cells, granulocytes and specific monocyte subsets.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18556075     DOI: 10.1016/j.regpep.2008.05.004

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  9 in total

1.  Short-term re-feeding of previously energy-restricted C57BL/6 male mice restores body weight and body fat and attenuates the decline in natural killer cell function after primary influenza infection.

Authors:  Jonathan F Clinthorne; Douglas J Adams; Jenifer I Fenton; Barry W Ritz; Elizabeth M Gardner
Journal:  J Nutr       Date:  2010-06-09       Impact factor: 4.798

2.  Expression of the leptin receptor outside of bone marrow-derived cells regulates tuberculosis control and lung macrophage MHC expression.

Authors:  Maria P Lemos; Kyu Y Rhee; John D McKinney
Journal:  J Immunol       Date:  2011-08-22       Impact factor: 5.422

3.  Leptin in sepsis: a well-suited biomarker in critically ill patients?

Authors:  Rodolfo Leonel Bracho-Riquelme; Miguel Arturo Reyes-Romero
Journal:  Crit Care       Date:  2010-04-09       Impact factor: 9.097

4.  Effects of Leptin on Intestinal Ischemia-Reperfusion Injury.

Authors:  Sevgi Buyukbese Sarsu; Bulent Hayri Ozokutan; Mehmet Tarakcioglu; Ibrahim Sarı; Cahit Bağcı
Journal:  Indian J Surg       Date:  2013-01-29       Impact factor: 0.656

5.  A Population Pharmacokinetic Model of Whole-Blood and Intracellular Tacrolimus in Kidney Transplant Recipients.

Authors:  Linda G Franken; Marith I Francke; Louise M Andrews; Ron H N van Schaik; Yi Li; Lucia E A de Wit; Carla C Baan; Dennis A Hesselink; Brenda C M de Winter
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2022-04-20       Impact factor: 2.569

Review 6.  Natural Killer Cell Dysfunction in Obese Patients with Breast Cancer: A Review of a Triad and Its Implications.

Authors:  Esraa Elaraby; Abdullah Imadeddin Malek; Hanan W Abdullah; Noha Mousaad Elemam; Maha Saber-Ayad; Iman M Talaat
Journal:  J Immunol Res       Date:  2021-06-07       Impact factor: 4.818

Review 7.  Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity.

Authors:  Ebtesam A Al-Suhaimi; Adeeb Shehzad
Journal:  Eur J Med Res       Date:  2013-05-01       Impact factor: 2.175

Review 8.  Immune Mechanisms Linking Obesity and Preeclampsia.

Authors:  Frank T Spradley; Ana C Palei; Joey P Granger
Journal:  Biomolecules       Date:  2015-11-12

Review 9.  Obesity-Associated Alterations of Natural Killer Cells and Immunosurveillance of Cancer.

Authors:  Ina Bähr; Julia Spielmann; Dagmar Quandt; Heike Kielstein
Journal:  Front Immunol       Date:  2020-03-13       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.